Leading hospital trade groups recently announced they are willing to seek a legislative solution to update the 340B Drug Discount Program. The move, years in the making, is timely and we applaud the effort. Why do we support it? Because it’s now undeniable that the current...
The Winter 340B Coalition conference was more like “Spring” from a timing perspective, and we associate springtime with new growth, vibrant colors, and hope for dark days to end and brighter days ahead. While San Diego is a great backdrop for sunshine and bright days,...
By 340B Matters Greed and political expediency can lead to the darkest places. Take the new group ASAP340B, an ungodly confederation of Big Pharma, Community Health Centers and a handful of organizations likely paid for by the drug industry. Improving the 340B Drug Discount Program is...
By 340B Matters The drug industry hates the 340B Drug Discount Program because it forces them to sell drugs at a lower cost to qualified non-profit health providers. So, to evade the law's requirements and generate more profits, manufacturers have hatched some creative schemes to reduce sales...
By 340B Matters The midterm elections have taken place and the next Congress will be sworn in next month. There’s a large incoming freshman class that will quickly need to understand Big Pharma’s greedy and illegal efforts to destroy the 340B Drug Discount Program. With the Republicans...
By 340B Matters It’s 365 days and counting since the Department of Health and Human Services referred scofflaw drug companies to the Office of Inspector General for assessment of civil monetary penalties for violating the 340B Drug Discount Program. It’s an anniversary that none of America’s...
By 340B Matters The 340B Drug Discount Program celebrates its 30th birthday this year. Over the past three decades, it has helped safety-net hospitals and clinics across the country care for underserved populations – just as Congress intended. These nonprofit healthcare organizations are on the front line....
By 340B Matters Big Pharma has been trying to maim or kill the 340B Drug Discount Program for years and hasn’t succeeded. That’s because it has enjoyed enormous bi-partisan support from successive presidential administrations as well as hundreds of members of the U.S. House and Senate. “Every...
By 340B Matters Recently, 25 state attorneys general signed onto two friend-of-the-court briefs excoriating the drug industry for illegally denying discounts to hospitals and clinics in the federal 340B Drug Discount Program. We applaud these leaders – and particularly Connecticut Attorney General William Tong, for leading...
By 340B Matters So far, seven of the world’s largest drug manufacturers have been referred to the Department of Health and Human Services Office of Inspector General for blatantly breaking the law regarding the 340B Drug Discount Program. The situation has cost affected hospitals and clinics $6...
